Literature DB >> 34244690

Quarter-dose of Moderna COVID vaccine still rouses a big immune response.

Elie Dolgin.   

Abstract

Entities:  

Keywords:  Immunology; Infection; Medical research; Public health; SARS-CoV-2; Vaccines

Year:  2021        PMID： 34244690     DOI： 10.1038/d41586-021-01893-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality.

Authors:  Benjamin J Cowling; Wey Wen Lim; Sarah Cobey
Journal:  Nat Med       Date:  2021-07-05       Impact factor: 53.440

2.  Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak - Final Report.

Authors:  Rebecca M Casey; Jennifer B Harris; Steve Ahuka-Mundeke; Meredith G Dixon; Gabriel M Kizito; Pierre M Nsele; Grace Umutesi; Janeen Laven; Olga Kosoy; Gilson Paluku; Abdou S Gueye; Terri B Hyde; Raimi Ewetola; Guylain K M Sheria; Jean-Jacques Muyembe-Tamfum; J Erin Staples
Journal:  N Engl J Med       Date:  2018-02-14       Impact factor: 91.245

3.  An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.

Authors:  Lisa A Jackson; Evan J Anderson; Nadine G Rouphael; Paul C Roberts; Mamodikoe Makhene; Rhea N Coler; Michele P McCullough; James D Chappell; Mark R Denison; Laura J Stevens; Andrea J Pruijssers; Adrian McDermott; Britta Flach; Nicole A Doria-Rose; Kizzmekia S Corbett; Kaitlyn M Morabito; Sijy O'Dell; Stephen D Schmidt; Phillip A Swanson; Marcelino Padilla; John R Mascola; Kathleen M Neuzil; Hamilton Bennett; Wellington Sun; Etza Peters; Mat Makowski; Jim Albert; Kaitlyn Cross; Wendy Buchanan; Rhonda Pikaart-Tautges; Julie E Ledgerwood; Barney S Graham; John H Beigel
Journal:  N Engl J Med       Date:  2020-07-14       Impact factor: 91.245

4.  A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.

Authors:  Laurence Chu; Roderick McPhee; Wenmei Huang; Hamilton Bennett; Rolando Pajon; Biliana Nestorova; Brett Leav
Journal:  Vaccine       Date:  2021-02-09       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.